4.6 (728) · $ 10.00 · In stock
There are fewer cancer deaths and more cancer therapies than ever, in part because scientists now design drugs to attack cancer based on its biology.
How a rare population of cancer cells contributes to relapse
Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries
Proposed model of TIMP-2 inhibition in ovarian cancer cells. a Effect
Madison Stief posted on LinkedIn
Emerging role of tumor cell plasticity in modifying therapeutic response
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics - ScienceDirect
Sustaining proliferative signaling pathways conserved from C. elegans
Nancy Abramson – Philly Fights Cancer
Current treatment options for advanced prostate cancer. Several classes
Cancers, Free Full-Text